✦ LIBER ✦

Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections

✍ Scribed by Cassandra Moran; Chelsea A. Grussemeyer; James R. Spalding; Daniel K. Benjamin Jr.; Shelby D. Reed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy and outcome of Candida glabrata

✍ Michael J. Klevay; Erika J. Ernst; Jesse L. Hollanbaugh; Joshua G. Miller; Micha 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Initial treatment and outcome of Candida

✍ Michael J. Klevay; David L. Horn; Dionissios Neofytos; Michael A. Pfaller; Danie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Nosocomial Bloodstream Infections: The A

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Candida albicans versus non-albicans blo

✍ Hung-Wei Chi; Ya-Sung Yang; Shi-Ta Shang; Ke-Hung Chen; Kuo-Ming Yeh; Feng-Yee C 📂 Article 📅 2011 🏛 Scientific Communications 🌐 English ⚖ 161 KB

Clinical and economic outcomes of decrea

✍ Ingi Lee; Knashawn H. Morales; Theoklis E. Zaoutis; Neil O. Fishman; Irving Nach 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Length of stay and charges associated wi

✍ Omar M. AL-Rawajfah; Jeanne Beauchamp Hewitt; Frank Stetzer; Jehanzeb Cheema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 154 KB